| |
| |
|
| Insider
Information: |
Pollard-Knight Denise |
| Relationship: |
Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
620,644 |
|
|
Indirect Shares
|
1,466,923 |
|
|
| Direct
Value |
$2,334,195 |
|
|
|
Indirect Value
|
$51,454,485 |
|
|
| Total
Shares |
2,087,567 |
|
|
| Total
Value |
$53,788,680 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Idenix Pharmaceuticals Inc |
IDIX |
Director |
2004-07-27 |
0 |
2005-11-14 |
301,476 |
Premium* |
|
|
Albireo Pharma Inc |
ALBO |
Director, 10% Owner |
2016-11-03 |
0 |
2016-11-03 |
1,165,447 |
Premium* |
|
|
Elanco Animal Health Inc |
ELAN |
|
2023-11-30 |
60,231 |
2019-04-11 |
0 |
Premium* |
|
|
Mereo Biopharma Group plc |
MREO |
Officer |
2024-01-01 |
560,413 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MREO |
Mereo Biopharma Group plc |
Chief Executive OfficerOfficer |
• – – |
2024-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
560,413 |
|
% |
|
| ELAN |
Elanco Animal Health Inc |
|
– • – |
2023-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
20,374 |
60,231 |
0 |
- |
|
| ELAN |
Elanco Animal Health Inc |
|
– • – |
2022-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,649 |
39,857 |
0 |
- |
|
| ELAN |
Elanco Animal Health Inc |
Director |
– • – |
2020-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
5,885 |
13,901 |
0 |
- |
|
| ELAN |
Elanco Animal Health Inc |
Director |
– • – |
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,233 |
8,016 |
0 |
- |
|
| ELAN |
Elanco Animal Health Inc |
Director |
– • – |
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,783 |
2,783 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • • |
2016-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,165,447 |
1,165,447 |
0 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
Director |
– • – |
2005-11-14 |
4 |
S |
$20.61 |
$12,973,954 |
I/I |
(629,498) |
301,476 |
|
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
Director |
– • – |
2004-07-27 |
4 |
D |
$14.00 |
$1,403,892 |
I/I |
(100,278) |
930,974 |
|
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
Director |
– • – |
2004-07-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,031,252 |
|
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
